High-Dose Atorvastatin Raises Threshold of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention: A Randomized Controlled Study
Background. Contrast-induced nephropathy (CIN) is a significant complication of angiographic procedures resulting from injection of iodinated contrast media (CM). Patients with diabetes mellitus (DM) are at the highest risk of CIN. Statins have recently been proposed for protection against CIN due t...
Автори: | Ahmed Abdel-Galeel, Salma Taha, Khaled M. Elmaghraby, Ramadan Ghaleb, Amr Hanafy, Fabrizio D’Ascenzo, M. Abdelfatah Elsharef, Lobna Abdel-Wahid, Ayman Ibrahim |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Hindawi-Wiley
2021-01-01
|
Серія: | Journal of Interventional Cardiology |
Онлайн доступ: | http://dx.doi.org/10.1155/2021/8862316 |
Схожі ресурси
Схожі ресурси
-
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
за авторством: Ayman Ibrahim, та інші
Опубліковано: (2020-12-01) -
Cardiac effects of direct anti-viral treatment in type II diabetic patients with hepatitis C infection
за авторством: Khaled M. Elmaghraby, та інші
Опубліковано: (2024-07-01) -
Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
за авторством: Peyman Bidram, та інші
Опубліковано: (2015-01-01) -
Correlation between ankle–brachial index, wall motion score index, and SYNTAX score in acute coronary syndrome patients
за авторством: Abdel-Galeel Ahmed, та інші
Опубліковано: (2022-06-01) -
Effects of combined use of atorvastatin and losartan in treating patients with diabetic nephropathy
за авторством: Chao Ding, та інші
Опубліковано: (2018-10-01)